Saudi-to-EU readiness
EU AI Act Audit Readiness for Saudi Companies
Assess EU connection, actor roles, classification and evidence using the amended 2026 timeline and a worked recruitment-software example.
A Saudi company can need an EU AI Act readiness review because of where it supplies an AI system, where it is used or where its outputs are used. The company's place of incorporation is only one part of the assessment. The first audit task is to establish the territorial connection, the company's role, the intended use and the provisions that apply to that combination.
This guide is for Saudi software providers, exporters and group compliance teams preparing evidence for EU-facing AI activities. It uses a hypothetical Saudi provider of recruitment-screening software offered to employers in the EU. The procedures are original readiness suggestions. Legal classification, applicable exceptions and formal conformity obligations require review by the responsible specialists for the actual product and deployment.
Use the amended timeline, not an old launch checklist
This page's legal-source review is dated 24 October 2026. The European Commission's current AI Act overview identifies the 2026 Digital Omnibus amendments as enacted, with entry into force on 27 July 2026. They should not be described as merely a pending proposal. The amending Regulation (EU) 2026/1744 changes important application dates.
| Area | Relevant date | Audit implication |
|---|---|---|
| General application | 2 August 2026, subject to exceptions | Do not assume all obligations are postponed with high-risk requirements |
| Initial prohibitions and AI literacy | 2 February 2025 | Review applicable existing obligations separately from future readiness work |
| GPAI and governance provisions | Relevant provisions applied from 2 August 2025 | Determine whether the company is a model provider or a downstream system actor |
| Chapter III, Sections 1–3 for Annex III high-risk systems | 2 December 2027, with the stated Article 6(5) exception | Plan evidence for the applicable high-risk system role and use |
| Chapter III, Sections 1–3 for Annex I high-risk systems | 2 August 2028, with the stated Article 6(5) exception | Check product legislation and the exact classification route |
The table is selective. Confirm the precise provisions, transitional arrangements and any later amendments in the current Article 113 text and related provisions. A future high-risk application date does not suspend separate privacy, employment or product obligations, nor does it make an unsupported product claim acceptable during preparation.
Establish the EU connection with actual commercial facts
Article 2 includes providers placing systems or general-purpose models on the EU market, EU deployers and certain third-country providers or deployers whose system outputs are used in the EU. The assessment must consider its scope and exceptions. A Saudi address does not by itself establish either exemption or applicability.
Request the product offering, contracting entities, customer locations, intended users and actual deployment routes. For the illustrative recruitment service, an EU employer uses screening outputs to prioritise applications. Record who offers the service, where the employer uses it and which entity operates each part. A globally accessible website alone is a different fact from an actual EU-facing supply arrangement.
Consider group arrangements separately. A Saudi group may operate a service internally while an EU subsidiary uses the output in its own recruitment process. The readiness review should map the factual relationship rather than assume that an internal transfer removes the territorial question. Record the legal assessment, the facts on which it relies and changes that would require reconsideration.
If the company has no relevant EU connection in the reviewed activity, state the basis and scope of that conclusion. Do not present an optional gap review as proof of a legal obligation. Equally, a plan to enter the EU market can justify readiness work before the first contract, provided the report makes the planned scenario explicit.
Determine the role before allocating evidence responsibilities
A Saudi organisation might provide an AI system, deploy someone else's system, distribute a product or participate in another role. These roles are not interchangeable. Identify the contractual and operational facts, branding, intended purpose and control over changes. A supplier's use of a third-party foundation model does not automatically make the supplier the provider of that general-purpose model.
Article 25 addresses circumstances in which responsibilities can shift along the AI value chain, including specified changes to branding, modification or intended purpose. Do not simplify this into “every configuration change makes the customer a provider.” The responsible legal assessment should examine the actual conditions and document the resulting role.
Build an evidence-responsibility matrix covering the Saudi system provider, model supplier, EU customer and any other relevant actor. Distinguish evidence that must be created by the organisation from information it needs from a supplier. A contract can allocate practical cooperation, but should not be assumed to rewrite statutory roles. Record gaps where the provider cannot obtain information needed for its own obligations.
Classify the intended use, including what it influences
Annex III identifies employment-related uses including recruitment and candidate evaluation. Article 6 contains the classification rules and conditions for relevant exceptions; its treatment of profiling must also be considered. Calling software an assistant does not settle the classification.
For the hypothetical product, compare the advertised purpose, instructions, interface and actual workflow. Does it merely format documents, or does it analyse and rank candidates for selection? Can users export a score into an applicant-tracking system? Does a supposedly optional recommendation determine which applications a recruiter sees? The audit supplies factual evidence for classification; it should not replace the authorised legal judgement.
Document any claimed exception with its reasoning and evidence. A narrow procedural description is weak if the implementation materially influences selection. If the company chooses a restricted intended use, examine how product design, instructions and monitoring support that boundary. A disclaimer contradicted by enabled functionality does not provide a dependable factual basis.
Worked product trace: follow a candidate-screening output
Use synthetic applications and fictional candidates in an authorised test environment. The illustrative audit follows a screening recommendation from input to recruiter action. Its purpose is to understand the system and test selected readiness claims; it does not approve the use of real applicants for an experiment or determine a lawful hiring outcome.
- Record the product version, intended use, configuration and input fields accepted by the service.
- Identify which fields are extracted, inferred or ignored, and what information reaches the model supplier.
- Generate the permitted screening output and preserve the explanation and limitations shown to the recruiter.
- Trace how the output affects ordering, filtering, exports and any subsequent workflow within scope.
- Test whether the recruiter can inspect the relevant source and override the output through the approved process.
- Confirm that corrections and relevant records remain linked to the tested version and case.
Suppose the interface displays a recommendation as advisory, but the default export excludes applications below a threshold before human review. That is an important factual difference for intended-use and oversight assessment. The finding should describe the observed filtering behaviour and its evidence, not automatically declare the legal classification without the agreed specialist decision.
Repeat relevant variations where the scope supports them: incomplete applications, mixed-language text, unusual formatting and conflicting source information. Record which cases are ordinary-use samples and which are targeted challenges. A set designed to reveal weaknesses should not be used to estimate the prevalence of those weaknesses in the customer population.
Build an evidence pack around claims, not document titles
For a provider preparing for applicable high-risk requirements, organise evidence so an authorised reviewer can connect the intended purpose, system description, data decisions, risk controls, evaluations, instructions and change history. The exact required documentation follows the applicable provisions and role. The matrix below is an original planning aid, not an official conformity checklist.
| Readiness claim | Evidence chain | Question that exposes a gap |
|---|---|---|
| The product's intended use is consistent | Product description, contract, instructions and enabled workflow | Does an export create a decision influence absent from the description? |
| Evaluation reflects the supplied system | Versioned test set, configuration, reference judgements and results | Were results produced on a different model or language configuration? |
| Oversight is usable | Interface evidence, role permissions and controlled correction tests | Can the reviewer change the result before it affects candidate visibility? |
| Supplier information supports provider responsibilities | Service terms, technical information and change notices | Which required system claim depends on unavailable supplier evidence? |
| Changes remain governed | Change assessment, approval, release evidence and updated instructions | Did the marketed purpose or decision influence change without review? |
Keep a traceable evidence index with dates and owners. Do not create a polished technical dossier that describes a future design while the marketed service operates differently. Where a control is planned but not implemented, label it accordingly. Where evidence covers only a limited pilot, do not imply that it demonstrates operation across every EU customer.
Evaluate data and performance without manufacturing certainty
Document the task definition, evaluation population, exclusions, reference process and model configuration. For the recruitment example, a benchmark should not silently treat historical hiring decisions as an unquestionable ground truth. The team needs a reasoned definition of the task and appropriate expertise to assess the reference judgements. The audit examines that reasoning and the evidence behind it.
Separate extraction quality, screening behaviour and the downstream decision. A system can extract a qualification correctly while applying an inappropriate ranking rule. A recruiter can override a weak suggestion while the product still hides some candidates by default. One aggregate accuracy figure cannot answer all three questions. Use evaluation integrity review and fairness testing for their specialised objectives.
Identify language and population limits. Evidence from English applications does not by itself establish performance on Arabic documents, and a global benchmark may not match the employer's actual workflow. State the supported conditions and the evidence needed for any extension. Avoid collecting additional personal data without a justified and authorised basis merely to fill an evaluation table.
Separate the provider's work from the deployer's operation
Article 26 addresses obligations of deployers of high-risk AI systems. A provider's readiness pack should help the customer understand the supplied system, but it cannot prove how every customer operates it. The audit should identify the boundary between product capabilities and customer responsibilities.
For example, the provider may supply an override function and usage instructions. The employer decides which authorised staff perform reviews and how outputs enter its recruitment process. Evidence that the function exists is different from evidence that the employer uses it effectively. Where the engagement covers both parties, obtain separate authority and evidence for each side.
Test whether instructions match the actual service and explain relevant limitations. A document that says “human review required” is weak if users cannot inspect the basis of a recommendation or cannot recover excluded applications. Escalate contradictions to the product and compliance owners, and determine whether the use needs restriction while the issue is addressed.
Do not assume every high-risk system needs a notified body
The conformity route depends on the applicable category and provisions. Article 43 provides an internal-control route for high-risk systems in Annex III points 2–8, while other categories and product legislation have different arrangements. A provider should not be sold a universal external-certification requirement merely because its system is described as high-risk.
Determine the actual route with the responsible specialists and any competent assessment body where required. A commercial readiness audit can identify evidence gaps and test controls, but it is not automatically the formal conformity procedure, a notified-body certificate or an EU regulatory approval. The report must describe the engagement it actually performed.
Keep ISO 42001 certification separate as well. A management-system certificate can provide relevant information about a scoped organisation, but it should not be presented as a blanket substitute for the product's applicable AI Act obligations. Map reusable evidence carefully and preserve the different decision-makers and conclusions.
Review transparency and other obligations on their own timetable
Article 50 contains transparency provisions for specified AI interactions and generated or manipulated content. Their applicability depends on the system and role. Do not postpone all transparency work simply because the high-risk readiness programme targets a later date.
Examine the product's actual user-facing interactions, notices and output channels. A recruitment service may include a conversational interface or generate content in addition to screening. Determine which provisions apply to those functions and who implements them. The audit should test the agreed disclosure behaviour where relevant, while avoiding a generic claim that every AI output must carry the same label.
Coordinate separate data-protection and employment assessments. A system can be prepared for one AI Act requirement while still having an unresolved personal-data processing question. For Saudi-side processing, PDPL-focused audit work may be relevant; EU-side privacy questions need their own applicable analysis. Do not collapse cross-border obligations into a single location or certificate check.
Maintain a change and evidence decision log
Record changes that may affect the assessment: new customer territories, altered intended use, additional ranking features, another model supplier or a new integration that changes decision influence. For each, identify the factual change, specialist review, affected evidence and decision before release. The process should distinguish a minor interface correction from a change that requires a new classification or conformity assessment analysis.
Preserve historical versions rather than overwrite the record. If the product was previously limited to document formatting and later gains candidate ranking, the earlier assessment describes the earlier product. A new marketing page should not silently inherit its conclusion. Similarly, a corrected evaluation does not establish what the old version did for past customers.
Use the log to coordinate commercial commitments. Sales teams should know which claims and markets are supported by current evidence and which remain conditional. An audit finding can require a narrower product statement or delayed feature release, not just another document. This connects readiness to the decisions that create exposure.
Make the commercial readiness decision explicit
A readiness report should distinguish several decisions that are often compressed into the word ready: whether the company understands its role, whether the product evidence is sufficient for a particular claim, whether a customer can conduct its own review, and whether the required formal route has been completed. Evidence supporting one decision may leave another open. Record the decision owner and the conditions attached to each proposed next step.
For the hypothetical recruitment product, a review might support a restricted demonstration using synthetic applications while finding that the customer-facing deployment pack is incomplete. That is an illustrative commercial planning conclusion, not a legal exemption for pilots. Any actual testing or deployment still needs its applicable assessment and authorisation. The report should say which environment, data and activities were considered rather than approve an undefined pilot.
Review the claims used in proposals and customer questionnaires. “Technical tests completed for version X” is different from “EU approved,” and a document marked draft should not be circulated as an adopted compliance position. Create a controlled list of supported statements and link each to its evidence owner. When a limitation changes, update the statements that depend on it.
Finally, define what would allow a deferred decision to be reconsidered. A missing supplier explanation, an unresolved classification question and a failed oversight test require different work. The action plan should name that work and its acceptance evidence, rather than ask the team to become compliant in general. This makes the audit useful to product, legal and sales teams without allowing a broad assurance claim to outrun the evidence.
Prepare a Saudi-to-EU audit scoping pack
Provide the intended EU connection, actor-role assessment, product-purpose description, classification decision, versioned architecture, supplier information and existing evidence. Identify the provisions and dates being assessed, along with open legal questions. Explain whether the goal is gap identification, technical testing, customer due diligence support or preparation for a defined conformity route.
An AI auditing engagement should report supported claims, observed exceptions, untested areas and the decisions that remain with authorised specialists. Request an EU AI Act readiness scoping discussion for a Saudi AI business with the actual product and market scenario. A useful result is a defensible evidence plan tied to the amended requirements and the company's role, without a blanket promise of EU compliance.
FAQ
Your questions, answered.
Can the EU AI Act apply to a Saudi AI company with no EU office?
Yes, an EU office is not the only possible connection. The assessment should examine supply into the EU, the actors involved and whether system outputs are used there, together with the relevant scope rules and exceptions. Record the actual commercial and operating facts. A Saudi incorporation address alone does not establish exemption, while a globally accessible website alone does not answer every applicability question.
What are the amended high-risk AI Act dates relevant in October 2026?
The amended Article 113 sets 2 December 2027 for Chapter III Sections 1–3 concerning Annex III high-risk systems, and 2 August 2028 for the corresponding Annex I category, with the stated Article 6(5) exception. These are not a postponement of every AI Act provision. Confirm the exact obligations, transitional rules and any subsequent amendments for the product and actor before relying on a readiness timetable.
Is Saudi recruitment-screening software automatically high-risk in the EU?
Recruitment and candidate evaluation are relevant Annex III categories, but classification requires the actual intended use and Article 6 analysis, including applicable conditions and profiling. Examine what the product does to candidate visibility, ranking and selection, not just its assistant label. A narrow procedural description should be supported by implementation evidence. The responsible specialists should document the classification and any claimed exception.
Does every high-risk AI system require a notified-body audit?
No universal rule should be assumed. Article 43 provides different conformity routes, including internal control for systems in Annex III points 2–8, while other categories and product legislation have different arrangements. Determine the route for the actual system. A commercial readiness review is not automatically a notified-body assessment, formal conformity procedure or regulatory approval, and its report should make that distinction clear.
Does using a foundation-model API make us the provider of that model?
Not automatically. Identify the organisation’s role for the supplied system and separately assess any obligations relating to a general-purpose model. Branding, intended purpose, development arrangements and changes can matter. A system provider still needs relevant supplier information for its own responsibilities, but should not assume that every upstream model obligation becomes its obligation merely because it uses an API.
Can ISO 42001 certification replace EU AI Act readiness work?
A scoped management-system certificate may provide relevant evidence about organisational processes, but it is not a blanket substitute for the product’s applicable requirements. Assess the actual system, actor role, intended use and conformity route. Reuse evidence where justified while preserving separate criteria and conclusions. Check the certificate’s scope rather than assuming it covers every product, subsidiary or customer deployment.
What should an EU-facing AI provider test before relying on human oversight?
Use authorised synthetic cases to examine what the reviewer sees, whether relevant sources and limitations are available, and whether an override changes the result before it affects the downstream workflow. Check exports and filters as well as the interface. A visible approval button or an instruction saying human review is required does not establish effective oversight by itself or prove every customer uses it properly.
What belongs in a Saudi company’s EU AI Act audit scoping pack?
Include the EU connection, actor-role assessment, intended-use statement, classification reasoning, versioned system description, supplier dependencies and existing evaluations. Identify the provisions and dates under review, open legal questions and the intended decision. Explain whether the engagement is a gap review, technical audit or preparation for a specific conformity route. This prevents a broad compliance label from concealing untested assumptions.